About

Important information

• Government Actions:

  Government Action: BBB reports on known government actions involving business’ marketplace conduct:

  Buffalo pharmacy pays more than $140,000 to settle record keeping and misbilling allegations
  

  The following describes a government action that has been resolved by either a settlement or a decision by a court or administrative agency. If the matter is being appealed, it will be noted below.

  BUFFALO, NEW YORK – U.S. Attorney Trini E. Ross announced today that Dexter Prescription Center a/k/a Dexter Pharmacy, has agreed to pay the United States $141,727 to resolve allegations that it violated the record keeping provisions of the Controlled Substances Act (CSA), and overcharged federal health care programs. 
  
  Assistant U.S. Attorney David M. Coriell, who handled the case, stated that the CSA requires entities that dispense controlled substances to maintain certain records and to conduct periodic inventories to prevent against diversion of controlled substances. An inspection by the U.S. Drug Enforcement Administration revealed that between January 1, 2018, and February 1, 2021, Dexter Pharmacy failed to maintain accurate records relating to its purchases and sales for certain controlled substances. Dexter Pharmacy also billed federal healthcare programs for medications, including controlled substances, that were never dispensed by Dexter Pharmacy. 

  This civil settlement agreement is not an admission of any liability by Dexter Pharmacy, nor a concession by the United States that its claims were not well-founded.

  Click here for details